Back
HFA Premium Access

Transendocardial injection of autologous expanded CD34+ Stem Cells (ProtheraCytes) promotes reverse cardiac remodeling in patients with left ventricular dysfunction after acute myocardial infarction

Session: Late breaking clinical trials II
Topic: Clinical
Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Event: Heart Failure 2024

Congress Presentation

Add to my library

Like

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
103 presentations
4 followers

9 more presentations in this session

Discussant review - EXCELLENT

Speaker: Professor F. Gustafsson (Copenhagen, DK)

Access
Slides
Video
Like
Thumbnail

Bio-ADM as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure; data from STRONG-HF

Speaker: Mr G. Voordes (Groningen, NL)

Access
Slides
Video
Like
Thumbnail

Discussant review - STRONG-HF

Speaker: Doctor A. Bayes Genis (Badalona, ES)

Access
Slides
Video
Like
Thumbnail

Semaglutide and cardiovascular outcomes in patients with overweight or obesity and heart failure: A pre-specified analysis from the SELECT trial

Speaker: Professor J. Deanfield (London, GB)

Access
Slides
Video
Like
Thumbnail

Discussant review - SELECT

Speaker: Professor P. Jhund (Glasgow, GB)

Access
Slides
Video
Like
Thumbnail

Access the full session

Late breaking clinical trials II

Speakers: Professor F. Zannad, Professor F. Gustafsson, Mr G. Voordes, Doctor A. Bayes Genis, Professor J. Deanfield...
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources